Barry Bratcher
Impact in
- Biotechnology top 1%
- Transgenic Plants and Applications
- Infectious Diseases top 5%
- Viral Infections and Outbreaks Research
- Viral Infections and Vectors
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
Papers in ⓘ
-
- Transgenic Plants and Applications 10
-
- Viral gastroenteritis research and epidemiology 3
- SARS-CoV-2 and COVID-19 Research 2
- Viral Infections and Outbreaks Research 2
- Co-authors
- Steven D. Hume (3 shared papers)Ernie Hiatt (5 shared papers)Kevin J. Whaley (8 shared papers)Larry Zeitlin (7 shared papers)Michael Pauly (7 shared papers)Josh Morton (9 shared papers)Gregory P. Pogue (7 shared papers)James Pettitt (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Vaccines (2 papers)mAbs (1 paper)Human Vaccines & Immunotherapeutics (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Africa
In The Last Decade
Barry Bratcher
12 papers receiving 890 citations
Peers
Comparison fields: 5 of 68
- Biotechnology 352
- Infectious Diseases 432
- Virology 85
- Microbiology 51
- Emergency Medical Services 53
Countries citing papers authored by Barry Bratcher
This map shows the geographic impact of Barry Bratcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Bratcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Bratcher more than expected).
Fields of papers citing papers by Barry Bratcher
This network shows the impact of papers produced by Barry Bratcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Bratcher. The network helps show where Barry Bratcher may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry Bratcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 258 | |
| 2 | 2009 | 208 | |
| 3 | 2013 | 167 | |
| 4 | 2010 | 135 | |
| 5 | 2021 | 48 | |
| 6 | 2013 | 42 | |
| 7 | 2023 | 15 | |
| 8 | 2012 | 15 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 4 |
About Barry Bratcher
Barry Bratcher is a scholar working on Biotechnology, Infectious Diseases, Molecular Biology, Immunology and Neurology, having authored 12 papers that have together received 926 indexed citations. Recurring topics across this work include Transgenic Plants and Applications (10 papers), Viral gastroenteritis research and epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Viral Infections and Outbreaks Research (2 papers), CRISPR and Genetic Engineering (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Food Allergy and Anaphylaxis Research (1 paper). The work is most often cited by research in Biotechnology (352 citations), Infectious Diseases (432 citations), Virology (85 citations), Microbiology (51 citations) and Emergency Medical Services (53 citations). Barry Bratcher has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Steven D. Hume, Ernie Hiatt, Kevin J. Whaley, Larry Zeitlin, Michael Pauly, Josh Morton, Gregory P. Pogue, James Pettitt, Ashley K. Johnson and Gene G. Olinger. Their work appears in journals such as Proceedings of the National Academy of Sciences, Vaccines, mAbs, Human Vaccines & Immunotherapeutics and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.